Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:948620rdf:typepubmed:Citationlld:pubmed
pubmed-article:948620lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:948620lifeskim:mentionsumls-concept:C0021246lld:lifeskim
pubmed-article:948620lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:948620lifeskim:mentionsumls-concept:C0033554lld:lifeskim
pubmed-article:948620lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:948620lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:948620pubmed:issue3lld:pubmed
pubmed-article:948620pubmed:dateCreated1976-10-1lld:pubmed
pubmed-article:948620pubmed:abstractTextThe effect of angiotensin II on peripheral levels of immunoreactive prostaglandin A2 (IR-PGA) was determined in 17 normal male volunteers. IR-PGA rose from 338 +/-65 (SE) pg/ml to 635+/-142 in response to pressor infusions of angiotensin II (p less than 0.05 on paired analysis). This increase was not observed when indomethacin, 75 mg p.o., was given to 8 patients two hours prior to a repeat infusion. Five patients of the original group were placed on a low sodium diet (10-20 mEg). The response to angiotensin was now exaggerated (278+/-52 pg/ml to 916+/-284). These five patients were kept on a low sodium intake and given indomethacin 50 mg p.o. g 6 hourly for 4 days. There was no significant rise with angiotensin infusion (106+/-31 pg/ml to 120+/-70). Pressor infusions of angiotensin II raise peripheral levels of IR-PGA, and this response is exaggerated by a low sodium diet and blocked by either acute or chronic indomethacin administration. This data supports the concept that vasodilatory prostaglandins may be released by endogenous angiotensin and thus provide a dynamic antagonism to the renin angiotensin system in man.lld:pubmed
pubmed-article:948620pubmed:languageenglld:pubmed
pubmed-article:948620pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:948620pubmed:citationSubsetIMlld:pubmed
pubmed-article:948620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:948620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:948620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:948620pubmed:statusMEDLINElld:pubmed
pubmed-article:948620pubmed:monthMarlld:pubmed
pubmed-article:948620pubmed:issn0090-6980lld:pubmed
pubmed-article:948620pubmed:authorpubmed-author:HortonRRlld:pubmed
pubmed-article:948620pubmed:authorpubmed-author:GolubMMlld:pubmed
pubmed-article:948620pubmed:authorpubmed-author:ZiaPPlld:pubmed
pubmed-article:948620pubmed:authorpubmed-author:SpeckartPPlld:pubmed
pubmed-article:948620pubmed:authorpubmed-author:ZipserRRlld:pubmed
pubmed-article:948620pubmed:issnTypePrintlld:pubmed
pubmed-article:948620pubmed:volume11lld:pubmed
pubmed-article:948620pubmed:ownerNLMlld:pubmed
pubmed-article:948620pubmed:authorsCompleteYlld:pubmed
pubmed-article:948620pubmed:pagination481-8lld:pubmed
pubmed-article:948620pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:948620pubmed:meshHeadingpubmed-meshheading:948620-H...lld:pubmed
pubmed-article:948620pubmed:meshHeadingpubmed-meshheading:948620-D...lld:pubmed
pubmed-article:948620pubmed:meshHeadingpubmed-meshheading:948620-M...lld:pubmed
pubmed-article:948620pubmed:meshHeadingpubmed-meshheading:948620-A...lld:pubmed
pubmed-article:948620pubmed:meshHeadingpubmed-meshheading:948620-I...lld:pubmed
pubmed-article:948620pubmed:meshHeadingpubmed-meshheading:948620-D...lld:pubmed
pubmed-article:948620pubmed:meshHeadingpubmed-meshheading:948620-P...lld:pubmed
pubmed-article:948620pubmed:year1976lld:pubmed
pubmed-article:948620pubmed:articleTitleThe effect of angiotensin II and indomethacin on immunoreactive prostaglandin "A" levels in man.lld:pubmed
pubmed-article:948620pubmed:publicationTypeJournal Articlelld:pubmed